Moore Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.33M	Hold	105,000	–	–	0.03%	342
2025 Q4	$1.08M	Hold	105,000	–	–	0.02%	441
2025 Q3	$609K	Hold	105,000	–	–	0.01%	470
2025 Q2	$706K	Hold	105,000	–	–	0.01%	405
2025 Q1	$949K	Hold	105,000	–	–	0.02%	322
2024 Q4	$1.82M	Hold	105,000	–	–	0.02%	336
2024 Q3	$1.68M	Hold	105,000	–	–	0.03%	319
2024 Q2	$1.5M	Hold	105,000	–	–	0.03%	287
2024 Q1	$1.49M	Hold	105,000	–	–	0.02%	284
2023 Q4	$1.58M	Hold	105,000	–	–	0.03%	247
2023 Q3	$1.66M	Hold	105,000	–	–	0.03%	263
2023 Q2	$1.59M	Hold	105,000	–	–	0.03%	270
2023 Q1	$1.52M	Hold	105,000	–	–	0.03%	264
2022 Q4	$1.42M	Hold	105,000	–	–	0.03%	308
2022 Q3	$1.66M	Hold	105,000	–	–	0.04%	377
2022 Q2	$1.28M	Hold	105,000	–	–	0.03%	378
2022 Q1	$986K	Hold	105,000	–	–	0.03%	424
2021 Q4	$1.8M	Buy	+105,000	New	+$2.55M	0.04%	414